Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOTECH Regulatory Filings 2016

Oct 3, 2016

9301_rns_2016-10-03_8aa206f5-dc5e-4068-974f-b324ffa016f4.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

THE BIOTECH GROWTH TRUST PLC - Statement Re Inside Information

PR Newswire

London, October 3

The Biotech Growth Trust PLC

3 October 2016

Compliance with Market Abuse Regulation – Statement Re Inside Information

The Biotech Growth Trust PLC (the “Company”)

The Directors of the Company confirm that they are satisfied that all inside information known to the Directors and the Company, in the period leading up to the announcement of the Company's half year results for the six-month period to 30 September 2016, has previously been, and will continue to be, notified to a Regulated Information Service ("RIS") and therefore dealings by the Company in its own securities are permitted.

If, in the period leading up to the announcement of the half year results, the Directors of the Company come into possession of any inside information, this will be notified to a RIS before any such transactions are undertaken. 

The mandatory closed period under the Market Abuse Regulation will commence 30 days prior to the publishing of the half year results to 30 September 2016.  It is anticipated that the closed period will commence on 7 October 2016 until the half year results are published on 9 November 2016.

Frostrow Capital LLP

Company Secretary

3 October 2016